Clinical Trial Update: A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating multiple intravenous doses of AbGn-168H in patients with moderate to severe chronic plaque psoriasis; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• AbGn-168H

Snippet

Sponsor: AbGenomics B.V Taiwan Branch | Conditions: Moderate to Severe Chronic Plaque Psoriasis | Phase 2 | Status: COMPLETED